Navigation Links
Digital mammography superior to film mammography in some cases
Date:1/28/2008

OAK BROOK, Ill. For some women, digital mammography may be a better screening option than film mammography, according to newly published results from the Digital Mammographic Imaging Screening Trial (DMIST). The results appear in the February issue of Radiology. The study found that digital mammography performed better than film mammography for pre- and perimenopausal women under age 50 with dense breasts.

We looked at a cross-section of characteristics, said DMIST principal investigator, Etta D. Pisano, M.D., Kenan professor of radiology and biomedical engineering at the University of North Carolina School of Medicine in Chapel Hill. This paper confirms that if you are under 50, pre- or perimenopausal, and have dense breasts, you should definitely be screened with digital rather than film.

DMIST enrolled 49,528 women at 33 centers in the U.S. and Canada. The women underwent both digital and film mammography. Breast cancer status was determined for 42,760 women.

The original DMIST results showed that digital was statistically similar to film in the overall screening population but performed better than film in pre- and perimenopausal women under 50, Dr. Pisano said.

For this paper, the researchers sought to retrospectively compare the accuracy of digital mammography versus film mammography in subgroups defined by combinations of age, menopausal status and breast density, using either biopsy results or follow-up information.

They compared results in 10 different subgroups of women: pre- and perimenopausal women under age 50 with fatty breasts, pre- and perimenopausal women under age 50 with dense breasts, postmenopausal women under 50 with fatty breasts, postmenopausal women under 50 with dense breasts, pre- and perimenopausal women between the ages of 50 and 64 with fatty breasts, pre- and perimenopausal women age 50 to 64 with dense breasts, postmenopausal women age 50 to 64 with fatty breasts, postmenopausal wom
'/>"/>

Contact: Linda Brooks
lbrooks@rsna.org
630-590-7762
Radiological Society of North America
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Digital Healthcare Wins FDA Approval for Retasure
2. Digital Healthcare Wins FDA Approval for Retasure
3. Astra Tech Acquires Innovative Dental Digital Technology Company
4. Digital Info Security Company and DGF MedServ, Inc. Announce Intent to Partner in Marketing DGIF IT Solutions to Medical Industry
5. Publicis Groupe Strengthens its Leadership in Digital and Integrated Healthcare Communications in Italy
6. Digital Healthcare Announces Dr. Michael Fleming Joins Executive Team as Medical Director
7. Siemens Rolls Out Its First Mobile Digital Mammography System in the U.S.
8. SMRT Architects and Engineers Selected to Design New $115M Digital X-Ray Manufacturing Facility for GE Healthcare
9. Digital Healthcare Announces Appointment of Dr. Suber Huang as Medical Director
10. Keeneland Scales Eklin Digital Repository(TM) to 32 Medical Image Review Workstations
11. Radlink Introduces New Family of Digital Imaging Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)... Though the number of jobs created i... companies reported a different kind of slowdown: ...s months. , Seattle, WA (...created in the medical field slowed in June overal...ind of slowdown that will be music to the ears of ...
(Date:7/25/2008)... supporting the US Department of Defense and Feder... Phoenix. Operation Golden Phoenix is a, four-da...ned to assist, federal, state and local agencies w...os. Dataline is providing a vital, ad-hoc, secure ... use during the exercise., NORFOLK, Va., July 25 ...
(Date:7/25/2008)...elationship Based on Significant Improvements in M...MDdatacor, Inc., a leader in health,care quality m..., today,announced it has entered into a long-term ...rt Wellmark,s Collaboration on Quality(SM) Incent ...ion between Wellmark and,primary care clinicians t...
(Date:7/25/2008)...URG, Ill., July 25 /PRNewswire/ -- Sagent Pharmace...utical company, today announced that it,has launch...arrhythmic,indicated for the treatment and prophyl...ion and hemodynamically unstable ventricular,tachy... heart beat.,Sagent,s amiodarone HCl injection wil...
Breaking Medicine News(10 mins):Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 2Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 3Health News:Dataline Announces Participation in Operation Golden Phoenix 2Health News:Dataline Announces Participation in Operation Golden Phoenix 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 3
...V and AIDS in India says that women and children a...the most likely one to be withdrawn// from school ...h AIDS. The National AIDS Control Organisation (NA...llion of the 5.2 million HIV/AIDS cases in India i...
... recently been developed by scientists. This appro...many malignancies before// they turn dangerous. Th... they have applied this technique to detect leukem...atic approach to diagnosing cancer at the molecula...
...researchers at the MassGeneral Institute for Neuro...bitor of an enzyme known as Poly //(ADP-ribose) po...untington’s disease affected cells from undergoing...rugs can be developed to treat Huntington's diseas...
...launched an International Stem Cell Research Insti...em cell research. // The academic medical center a...lopmental geneticist Nissim Benvenisty, M.D., Ph.D...g with David I. Meyer, Ph.D., vice president of Re...
Other Medicine News:Health News:New Technique To Diagnose Cancer At Molecular Level 2Health News:Targeting PARP1 Is Effective In Protecting HD Cells from Damage 2Health News:Center Launches New International Stem Cell Research Institute 2
(Date:7/23/2008)... SAN FRANCISCO, July 23 /- InCode Bio... company, today announced preclinical test,results...idate rC3-1 for,the treatment of the rare chronic ... (PNH). The complete results will be presented at ...l, Switzerland, September 28,2008., The only tre...
(Date:7/22/2008)... - Strong efficacy results from a multi-center 293....com , Toronto Stock Exchange Symbol: CYT, MONTR...Technologies,Inc., the global leader in cryotherap...ounced that results previously presented from thre...product, Arctic Front(R),were published earlier t...
(Date:7/22/2008)...Study Demonstrates Feasibility and Efficacy of Tre...ry Liver Cancer, SAN FRANCISCO, and YONGIN-SI, So...(San Francisco, CA and Ottawa, Ontario), and its S...oday that novel findings from,a Phase I clinical t...onstrated that the product was well-tolerated and ...
(Date:7/22/2008)... SOUTH SAN FRANCISCO, Calif., July 22 /PRNewswire/...at it has completed patient enrollment,in its Phas...ability and,ammonia scavenging effects of HPN-100 ...phenylbutyrate) in patients with urea cycle disord...results in the fourth quarter,of this year., (Log...
Breaking Medicine Technology:InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3New Jersey Leaders Join Forces to Battle Chronic Disease 16998 1New Jersey Leaders Join Forces to Battle Chronic Disease 16998 2New Jersey Leaders Join Forces to Battle Chronic Disease 16998 3New Jersey Leaders Join Forces to Battle Chronic Disease 16998 4NYU Medical Center Changes Name to Honor Chairman of Board 26 Wife 4649 1NYU Medical Center Changes Name to Honor Chairman of Board 26 Wife 4649 2NYU Medical Center Changes Name to Honor Chairman of Board 26 Wife 4649 3NYU Medical Center Changes Name to Honor Chairman of Board 26 Wife 4649 4NYU Medical Center Changes Name to Honor Chairman of Board 26 Wife 4649 5Low Vitamin D Levels Linked to Leg Artery Blockages 16994 1Low Vitamin D Levels Linked to Leg Artery Blockages 16994 2Low Vitamin D Levels Linked to Leg Artery Blockages 16994 3Older people are nations happiest 16991 1Older people are nations happiest 16991 2
... in a randomized phase II/III clinical trial,antic...Newswire-FirstCall/ -- Cell,Therapeutics, Inc. (CT...s, which demonstrate that treatment with pixantron... cardiotoxicity, while,doxorubicin and mitoxantron...compared the cardiac side effects of equiactive do...
....--(BUSINESS WIRE)--Jun 26, 2007 - Sirtris,Pharmac... company,focused on discovering and developing sma...unced today that activation of SIRT1, a,member of ...t,against neurodegenerative diseases such as Alzhe...n animal models. These findings,appear in an artic...
Other Medicine Technology:Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 2Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 3Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 4Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 5Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 6Resveratrol Studies Suggest Broad Implications for SIRT1 Activation,in Neurodegenerative Diseases of Aging Such as Alzheimer's Disease 2Resveratrol Studies Suggest Broad Implications for SIRT1 Activation,in Neurodegenerative Diseases of Aging Such as Alzheimer's Disease 3
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: